Annual Interest Expense
N/A
30 April 2024
Summary:
PharmaCyte Biotech annual interest expense is not available.PMCB Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
31 July 2024
Summary:
PharmaCyte Biotech quarterly interest expense is not available.PMCB Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
31 July 2024
Summary:
PharmaCyte Biotech TTM interest expense is not available.PMCB TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
PMCB Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
PharmaCyte Biotech Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2022 | $500.00(-83.3%) | $0.00(0.0%) | $500.00(-66.7%) |
Jan 2022 | - | $0.00(0.0%) | $1500.00(-11.8%) |
Oct 2021 | - | $0.00(-100.0%) | $1700.00(-29.2%) |
July 2021 | - | $500.00(-50.0%) | $2400.00(+4.3%) |
Apr 2021 | $3000.00(+500.0%) | $1000.00(+400.0%) | $2300.00(+27.8%) |
Jan 2021 | - | $200.00(-71.4%) | $1800.00(+12.5%) |
Oct 2020 | - | $700.00(+75.0%) | $1600.00(+77.8%) |
July 2020 | - | $400.00(-20.0%) | $900.00(+80.0%) |
Apr 2020 | $500.00(>+9900.0%) | $500.00(>+9900.0%) | $500.00(>+9900.0%) |
Jan 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
Oct 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
July 2019 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Apr 2019 | $0.00 | - | - |
Jan 2017 | - | $100.00(-75.0%) | $500.00(0.0%) |
Oct 2016 | - | $400.00(+300.0%) | $500.00(+66.7%) |
Jan 2016 | - | $100.00(-50.0%) | $300.00(+50.0%) |
Oct 2015 | - | $200.00(-94.7%) | $200.00(-98.9%) |
Jan 2014 | - | $3800.00(+5.6%) | $17.80 K(-1.1%) |
Oct 2013 | - | $3600.00(-65.4%) | $18.00 K(-78.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
July 2013 | - | $10.40 K(+160.0%) | $81.70 K(-68.1%) |
Jan 2013 | - | $4000.00(-94.1%) | $256.00 K(-11.0%) |
Oct 2012 | - | $67.30 K(+46.0%) | $287.80 K(+13.4%) |
July 2012 | - | $46.10 K(-66.7%) | $253.90 K(+5.3%) |
Apr 2012 | $241.20 K(+40.5%) | $138.60 K(+287.2%) | $241.20 K(+75.5%) |
Jan 2012 | - | $35.80 K(+7.2%) | $137.40 K(-12.4%) |
Oct 2011 | - | $33.40 K(0.0%) | $156.90 K(+4.5%) |
July 2011 | - | $33.40 K(-4.0%) | $150.10 K(-12.5%) |
Apr 2011 | $171.70 K(-41.3%) | $34.80 K(-37.1%) | $171.60 K(-30.5%) |
Jan 2011 | - | $55.30 K(+107.9%) | $247.00 K(-2.7%) |
Oct 2010 | - | $26.60 K(-51.5%) | $253.90 K(-7.9%) |
July 2010 | - | $54.90 K(-50.2%) | $275.80 K(-4.9%) |
Apr 2010 | $292.60 K(+701.6%) | $110.20 K(+77.2%) | $289.90 K(+34.7%) |
Jan 2010 | - | $62.20 K(+28.2%) | $215.20 K(+40.3%) |
Oct 2009 | - | $48.50 K(-29.7%) | $153.40 K(+46.1%) |
July 2009 | - | $69.00 K(+94.4%) | $105.00 K(+188.5%) |
Apr 2009 | $36.50 K | $35.50 K(+8775.0%) | $36.40 K(+3944.4%) |
Jan 2009 | - | $400.00(+300.0%) | $900.00(+80.0%) |
Oct 2008 | - | $100.00(-75.0%) | $500.00(+25.0%) |
July 2008 | - | $400.00 | $400.00 |
FAQ
- What is the all time high annual interest expense for PharmaCyte Biotech?
- What is the all time high quarterly interest expense for PharmaCyte Biotech?
- What is the all time high TTM interest expense for PharmaCyte Biotech?
What is the all time high annual interest expense for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual interest expense is $292.60 K
What is the all time high quarterly interest expense for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly interest expense is $138.60 K
What is the all time high TTM interest expense for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM interest expense is $289.90 K